Published in Cell Immunol on November 01, 1974
Cytotoxic T cells specific for influenza virus-infected target cells. Immunology (1977) 2.24
Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12
Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect Immun (1975) 1.78
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun (1976) 1.59
Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med (1980) 1.35
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells. Immunology (1976) 1.27
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells. Immunology (1976) 1.21
Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J Immunol (2008) 1.19
Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol (2006) 1.14
Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08
Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+. Immunology (1980) 1.01
Requirement for non-T cells in the generation of cytotoxic T lymphocytes in vitro. I. Use of nude mice as source of non-T cells. J Exp Med (1976) 0.96
Autoreactivity developing spontaneously in cultured mouse spleen cells. I. Evidence that cytotoxicity is directed against embryo-associated antigen. Immunology (1976) 0.95
Primary in vitro cytotoxic T cell response to non-major histocompatibility complex alloantigens in normal mice. J Exp Med (1982) 0.94
Gamma delta T cells differentiate into a functional but nonproliferative state during a normal immune response. Proc Natl Acad Sci U S A (1993) 0.94
Comparison of T cell-mediated immune responsiveness of NZB, (NZB x &NZW)F1 hybrid and other murine strains. Clin Exp Immunol (1977) 0.89
Convolution of chemoattractant secretion rate, source density, and receptor desensitization direct diverse migration patterns in leukocytes. Integr Biol (Camb) (2013) 0.83
T cell-mediated immune responses of lupus-prone BXSB mice and other murine strains. Clin Exp Immunol (1979) 0.83
Autoreactivity developing spontaneously in cultured mouse spleen cells. II. Comparison of cytotoxicity of cultured male and female spleen cells. Immunology (1976) 0.82
Stimulation of human NK cell activity by cultured cells. II Ingestion of aspirin by blood donors suppresses induced NK activity. Clin Exp Immunol (1981) 0.75
Differential expression of RT1 class II genes in fibroblast cell lines: recognition by allogeneic and xenogeneic T lymphocytes. Immunology (1986) 0.75
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Separation of suppressor and killer T cells by surgace phenotype. Nature (1976) 3.03
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22
Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (1992) 2.22
Subacute, reversible motor neuron disease. Neurology (1991) 2.20
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am Rev Respir Dis (1982) 2.07
Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis. J Appl Physiol (1985) (2000) 2.04
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
What price Kaplan-Meier? Biometrics (1983) 1.73
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology (1993) 1.61
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med (2010) 1.56
Central basis of muscle fatigue in chronic fatigue syndrome. Neurology (1993) 1.52
Prognosis in AZT myopathy. Neurology (1991) 1.50
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia (2007) 1.44
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol (1996) 1.41
An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature (1980) 1.40
Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol (1981) 1.39
Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci U S A (1981) 1.37
Atomic force microscopy of purple membranes. J Microsc (1988) 1.35
Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35
Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med (1980) 1.35
The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep (1984) 1.29
Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol (1993) 1.27
The cubital tunnel syndrome: diagnosis and precise localization. Ann Neurol (1979) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging (1994) 1.24
Particle rosettes in the periaxonal Schwann cell membrane and particle clusters in the axolemma of rat sciatic nerve. Brain Res (1977) 1.23
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol (1994) 1.23
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
The natural history of amyotrophic lateral sclerosis. Neurology (1993) 1.21
Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. J Immunol (1973) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci (2001) 1.19
Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. Cancer Res (1979) 1.19
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol (1985) (1997) 1.16
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
Chlorine dioxide water disinfection: a prospective epidemiology study. Arch Environ Health (1981) 1.16
Synchronization of mouse L-cells by a velocity sedimentation technique. Biophys J (1970) 1.15
Nerve conduction studies in infants and children. J Child Neurol (1986) 1.14
Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol (1993) 1.14
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology (2002) 1.12
Adiposity and mortality in type 1 diabetes. Int J Obes (Lond) (2009) 1.12
Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells. J Cell Physiol (1977) 1.11
Sedimentation analysis of the cells in mice required to initiate an in vivo immune response to sheep erythrocytes. Proc Soc Exp Biol Med (1970) 1.11
Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol (1992) 1.10
A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol (1979) 1.10
Palliative care in amyotrophic lateral sclerosis. Neurol Clin (2001) 1.10
Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules. Muscle Nerve (1989) 1.09
Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol (1983) 1.09
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology (1998) 1.09
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology (1998) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
In vitro differentiation of B lymphocytes from pre-B cells. J Immunol (1979) 1.09
Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve (1986) 1.08
Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sex Transm Dis (1987) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. V. The cellular basis for the cross-reactivity of TNP-specific clones. J Immunol (1978) 1.07
Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science (1991) 1.06
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology (1995) 1.06
Restriction of specificity in the precursors of bone marrow-associated lymphocytes. J Exp Med (1973) 1.05
Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol (1992) 1.05
Sporadic distal myopathy with early adult onset. Ann Neurol (1979) 1.05
Volume analysis of human peripheral blood leukocytes. Ser Haematol (1972) 1.05
Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology (2001) 1.05
Membrane particles on fracture faces of frozen myelin. Proc Natl Acad Sci U S A (1975) 1.04
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4. Infect Immun (1993) 1.04
Marrow environment not required for differentiation of B lymphocytes. Nature (1974) 1.04
Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve (1998) 1.03
Inhibition of the immune response by 7S antibody mechanism and site of action. J Exp Med (1973) 1.03
Chancroidal ulcers that are not chancroid. Cause and epidemiology. Arch Dermatol (1984) 1.02
Conduction block in clinical practice. Muscle Nerve (1991) 1.02
Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A. J Immunol (1977) 1.01
Measurement of cytoplasmic fluorescence depolarization of single cells in a flow system. J Histochem Cytochem (1977) 1.00